---
figid: PMC8720382__gr7_lrg
figtitle: Integrated hepatic single-cell RNA sequencing and untargeted metabolomics
  reveals the immune and metabolic modulation of Qing-Fei-Pai-Du decoction in mice
  with coronavirus-induced pneumonia
organisms:
- Human coronavirus 229E
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8720382
filename: gr7_lrg.jpg
figlink: /pmc/articles/PMC8720382/figure/fig0007/
number: F7
caption: 'QFPDD treatment significantly regulated liver purine metabolism pathway
  in pneumonia mice. Metabolites involved in aminoacyl-tRNA biosynthesis (A) and other
  pathways (arginine biosynthesis, glutathione metabolism, alanine, aspartate and
  glutamate metabolism, arginine and proline metabolism, d-Glutamine and d-glutamate
  metabolism, TCA cycle, and beta-Alanine metabolism) (B) were significantly altered
  in the Model group (n = 8), and QFPDD treatment regulated purine metabolism related
  metabolites (C). * p < 0.05, ** p < 0.01 compared with Con group. #p < 0.05, ##p<0.01
  compared with Model group, based on Student''s t-test. Blue arrows imply significant
  downregulation while red arrows imply significant upregulation in the Model group,
  compared to the Con group. Results are presented as means ± SEM.'
papertitle: Integrated hepatic single-cell RNA sequencing and untargeted metabolomics
  reveals the immune and metabolic modulation of Qing-Fei-Pai-Du decoction in mice
  with coronavirus-induced pneumonia.
reftext: Saisai Tian, et al. Phytomedicine. 2022 Mar;97:153922-153922.
year: '2022'
doi: 10.1016/j.phymed.2021.153922
journal_title: Phytomedicine
journal_nlm_ta: Phytomedicine
publisher_name: Elsevier GmbH.
keywords: Qing-Fei-Pai-Du decoction | Single-cell RNA sequencing | Untargeted metabolomics
  | Coronavirus disease 2019 | Cold-damp environment | ADP, adenosine diphosphate
  | AMP, Adenosine monophosphate | AMPK, Adenosine monophosphate-activated protein
  kinase | ATP, adenosine triphosphate | Con, Control group | COVID-19, coronavirus
  disease 2019 | DEGs, differentially expressed genes | GC-TOF/MS, gas chromatography-time-of-flight
  mass spectrometry | HCoV-229E, Human coronavirus 229E | malonyl-CoA, malonyl-coenzyme
  A | MERS, Middle East respiratory syndrome | QFPDD, Qing-Fei-Pai-Du decoction |
  QFPDD_H, high dosage QFPDD treatment group | QFPDD_L, low dosage QFPDD treatment
  group | QFPDD_M, middle dosage QFPDD treatment group | RAS, renin angiotensin system
  | RSS, regulon specificity score | SARS-CoV-2, severe acute respiratory syndrome
  coronavirus 2 | SCENIC, single-cell regulatory network inference and clustering
  | TCA, the citric acid | TCM, traditional Chinese medicine
automl_pathway: 0.6944533
figid_alias: PMC8720382__F7
figtype: Figure
redirect_from: /figures/PMC8720382__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8720382__gr7_lrg.html
  '@type': Dataset
  description: 'QFPDD treatment significantly regulated liver purine metabolism pathway
    in pneumonia mice. Metabolites involved in aminoacyl-tRNA biosynthesis (A) and
    other pathways (arginine biosynthesis, glutathione metabolism, alanine, aspartate
    and glutamate metabolism, arginine and proline metabolism, d-Glutamine and d-glutamate
    metabolism, TCA cycle, and beta-Alanine metabolism) (B) were significantly altered
    in the Model group (n = 8), and QFPDD treatment regulated purine metabolism related
    metabolites (C). * p < 0.05, ** p < 0.01 compared with Con group. #p < 0.05, ##p<0.01
    compared with Model group, based on Student''s t-test. Blue arrows imply significant
    downregulation while red arrows imply significant upregulation in the Model group,
    compared to the Con group. Results are presented as means ± SEM.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATP8A2
  - APRT
  - MFAP1
  - WDTC1
  - FGFR1
  - Con
  - ATPsynbeta
  - Atpalpha
  - Amph
  - adp
  - CycE
  - cyc
---
